- Home
- PFSA vs SNES Comparison
PFSA vs SNES Comparison
Compare PFSA & SNES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PFSA
- SNES
- Stock Information
- Founded
- PFSA 2009
- SNES 2004
- Country
- PFSA United States
- SNES United States
- Employees
- PFSA N/A
- SNES N/A
- Industry
- PFSA Medical/Dental Instruments
- SNES Agricultural Chemicals
- Sector
- PFSA Health Care
- SNES Industrials
- Exchange
- PFSA Nasdaq
- SNES Nasdaq
- Market Cap
- PFSA 25.1M
- SNES 21.0M
- IPO Year
- PFSA N/A
- SNES 2016
- Fundamental
- Price
- PFSA $0.50
- SNES $4.67
- Analyst Decision
- PFSA
- SNES Strong Buy
- Analyst Count
- PFSA 0
- SNES 1
- Target Price
- PFSA N/A
- SNES $10.00
- AVG Volume (30 Days)
- PFSA 7.9M
- SNES 195.8K
- Earning Date
- PFSA 01-01-0001
- SNES 08-07-2025
- Dividend Yield
- PFSA N/A
- SNES N/A
- EPS Growth
- PFSA N/A
- SNES N/A
- EPS
- PFSA N/A
- SNES N/A
- Revenue
- PFSA $75,000.00
- SNES $2,093,000.00
- Revenue This Year
- PFSA N/A
- SNES $130.53
- Revenue Next Year
- PFSA N/A
- SNES $80.00
- P/E Ratio
- PFSA N/A
- SNES N/A
- Revenue Growth
- PFSA 150.00
- SNES 36.89
- 52 Week Low
- PFSA $0.46
- SNES $1.30
- 52 Week High
- PFSA $5.50
- SNES $6.24
- Technical
- Relative Strength Index (RSI)
- PFSA N/A
- SNES 46.89
- Support Level
- PFSA N/A
- SNES $4.47
- Resistance Level
- PFSA N/A
- SNES $6.24
- Average True Range (ATR)
- PFSA 0.00
- SNES 0.41
- MACD
- PFSA 0.00
- SNES -0.13
- Stochastic Oscillator
- PFSA 0.00
- SNES 19.03
About PFSA Profusa Inc. Common Stock
Profusa Inc is a digital health technology company based in Emeryville, CA, that has developed a real-time, consumer-friendly platform that is designed to measure an individual's biochemistry, be easy to use, be cost-effective, and provide the necessary data to manage chronic disease and health and wellness decisions to improve health outcomes for a large population of potential users. The Company's technology enables the development of bioengineered sensors that are designed to become one with the body to detect and continuously transmit actionable, clinical-grade data for personal and medical use. The Company's first offering in the European Union, the Lumee Oxygen Platform, is designed to report reliable tissue oxygen levels at various regions of interest, both acutely and long-term.
About SNES SenesTech Inc.
SenesTech Inc is a United States-based biotech platform and research company engaged in developing technology for managing animal pest populations through fertility control. The company provides its solutions to the animal market, commercial markets, and food markets. It currently has two product lines of fertility control products: ContraPest and Evolve.